Previous 10 | Next 10 |
home / stock / ctabf / ctabf news
Canntab Therapeutics (OTCQB:CTABF) signed an agreement with First Nations Growers GP to create an Indigenous Opiate and Illicit Drug Crisis Plan. The plan will make Canntab's full suite of oral tablet products, which include a range of tetrahydrocannabinol (THC) and cannabidio...
CANNTAB SIGNS HISTORIC AGREEMENT WITH FIRST NATIONS GROWERS GP INC. TO ADDRESS THE OPIATE AND ILLICIT DRUG CRISIS AFFECTING INDIGENOUS PEOPLES THROUGHOUT CANADA Canada NewsWire TORONTO , Feb. 7, 2022 /CNW/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:...
CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE Canada NewsWire TORONTO , Feb. 1, 2022 /PRNewswire/ -- Canntab Therapeutics Limited ("Canntab" or the "Company") (CSE:PILL) (OTCQB:CTABF) (FRA:TB...
CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM Canada NewsWire TORONTO , Jan. 20, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in h...
The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into new verticals in the future Levitee Labs and Canntab Therapeutics have executed a services agreement resulting in Levitee Labs i...
CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA Canada NewsWire TORONTO , Jan. 10, 2022 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN ) ( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " ...
Canntab Therapeutics (OTCQB:CTABF) has entered into a service agreement with Levitee Clinics. Levitee aims to transform mental health and addiction treatments through the integration of alternative medicinal therapies. Agreement with Levitee to service over 35,000 annual patient visits ...
CANNTAB ENTERS INTO STRATEGIC PARTNERSHIP TO PROVIDE ALTERNATIVES TO OPIATES THROUGH LEVITEE CLINICS Canada NewsWire Agreement with Levitee to service over 35,000 annual patient visits with the aim to help treat their patients with substance use addictions and chro...
Canntab Announces Agreement with Pathway Health Canada NewsWire TORONTO , Dec. 2, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab" ), the leading innovator in cannabinoid and te...
Canntab Receives Medical Sales Licence from Health Canada Canada NewsWire TORONTO , Nov. 11, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab" ), the leading innovator in cannabinoid and...
News, Short Squeeze, Breakout and More Instantly...
Canntab Therapeutics Ltd Company Name:
CTABF Stock Symbol:
OTCMKTS Market:
Canntab Therapeutics Ltd Website:
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the " Corporation ") announces that the Ontario Securities Commission (the " OSC ") has rejected the Corporation's application for a management cease trade order (the ...
TORONTO, ON / ACCESSWIRE / November 22, 2022 / Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impac...
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabi...